文献速递骨质疏松与代谢性骨病

使用种族中立美国FRAX后治疗资格变化有限:基于国家健康与营养调查(NHANES)的估计

Changes in treatment eligibility with race-neutral US FRAX would be modest: estimates using the National Health and Nutrition Examination Survey (NHANES).
PubMed 文献 · Osteoporos Int · 2025-12-14

研究分析NHANES 2013-2014和2005-2010参与者,比较种族特异与种族中立FRAX计算的治疗资格差异。总体治疗资格变化小于5%,黑人、西班牙裔和亚裔参与者略有增加,白人参与者略有下降。

要点

  • 种族中立FRAX使黑人、西班牙裔、亚裔女性治疗资格小幅增加,白人女性小幅下降。
  • 男性治疗资格变化更小。
  • 总体治疗资格绝对变化小于5%。

核心结论

  • 将美国FRAX改为种族中立计算器仅会适度增加美国黑人、西班牙裔和亚裔人群的治疗资格,同时轻微降低白人人群的治疗资格。

研究设计与样本

  • 分析NHANES 2013-2014和2005-2010参与者,基于问卷和骨密度计算当前FRAX,并使用人口普查数据计算种族中立FRAX,比较两种计算器基于主要骨质疏松性骨折(MOF)20%或髋部骨折3%阈值的治疗资格。

主要发现

  • 在NHANES 2013-2014的3035名参与者中,使用种族中立FRAX后,白人女性治疗资格从18.4%降至14.9%,黑人女性从1.9%升至5.2%,西班牙裔女性从3.9%升至7.0%,亚裔女性从9.3%升至12.6%。
  • 男性治疗资格变化更小。
  • 在NHANES 2005-2010的8458名参与者中,治疗资格绝对变化小。

关键数值与推荐

  • 美国FRAX根据历史数据将黑人、西班牙裔和亚裔人群的概率下调0.43-0.64。
  • ASBMR工作组建议创建基于人群的种族中立计算器。
  • 治疗资格阈值:MOF 20%或髋部骨折3%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: To understand the effects of removing race from fracture calculators, we analyzed the changes in osteoporosis treatment eligibility between race-specific and race-neutral FRAX in NHANES. Overall, we found small changes in treatment eligibility (< 5%) with slight increases among Black, Hispanic, and Asian participants and a slight decrease among White participants. PURPOSE: The Fracture Risk Assessment Tool (FRAX) calculates the 10-year risk of major osteoporotic fracture (MOF) and hip fracture. In the USA, the calculator adjusts the probability down by 0.43-0.64 in Black, Hispanic, and Asian people based on historical data. Recently, an ASBMR Taskforce recommended the creation of a population-based, race-neutral calculator. The effects of this recommendation on treatment eligibility are not clear, so this study sought to quantify changes in treatment eligibility in the National Health and Nutrition Examination Survey (NHANES). METHODS: We analyzed participants in NHANES 2013-2014 and 2005-2010 and calculated the current FRAX based on questionnaires and bone mineral density (BMD). We then calculated a separate race-neutral FRAX using census data and compared treatment eligibility between the two calculators based on thresholds of 20% for MOF or 3% for hip fracture. We also examined treatment eligibility based on either clinical criteria (BMD T-score ≤ -2.5 or prior hip or vertebral fracture) or FRAX eligibility. RESULTS: Among 3035 and 8458 participants in NHANES 2013-2014 and 2005-2010, we found small absolute changes to treatment eligibility. In NHANES 2013-2014, the percent eligible using race-neutral FRAX decreased from 18.4 to 14.9% for White women and increased from 1.9 to 5.2% for Black women, from 3.9 to 7.0% for Hispanic women, and from 9.3 to 12.6% for Asian women. Changes in men were even smaller. CONCLUSION: We found that changing US FRAX to a race-neutral calculator would only modestly increase treatment eligibility in US Black, Hispanic, and Asian people, while slightly decreasing eligibility in White people.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Jain RK. Changes in treatment eligibility with race-neutral US FRAX would be modest: estimates using the National Health and Nutrition Examination Survey (NHANES). Osteoporos Int. 2025. PMID: 41392042. doi:10.1007/s00198-025-07804-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。